HPBCD against acute and subacute infarcts in a mouse model of ischemic stroke
HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously
HPBCD against acute and subacute infarcts in a mouse model of ischemic stroke
HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously
Special issue: Novel macrocycles: from synthesis to supramolecular function
This thematic issue in Beilstein Journal of Organic Chemistry aims at collecting new discovies on macrocycles such as cucurbiturils, calixarenes,
Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
For years, oat milk has been one of the most successful plant-based dairy alternatives, winning over consumers with its creamy
Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
Cyclodextrin-based metal-organic frameworks (CD-MOFs) constitute a distinctive family of porous solids that combine the modularity of coordination networks with the
Exploring Cyclodextrin-Based MOFs for Drug Delivery: Synthesis, Applications, and Future Perspectives
3D cyclodextrin-based metal-organic frameworks (CD-MOFs) have emerged as a biocompatible alternative to conventional MOFs, as they are synthesized using safer,
Sugammadex analog water soluble BCD polymer for peptide complexes
In this work, an integrated biophysical and biological study is presented describing both the structural and biological features of the
2 nd International Conference on Biomedical Science and Engineering
The 2nd International Conference on Biomedical Science and Engineering will be held on June 22-23, 2026 in London. Conference Sessions
Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery
Compared with neostigmine, sugammadex promotes faster neuromuscular recovery, but its impact on diaphragmatic function and respiratory recovery in the morbidly
Cyclodextrin-Amino Acid Conjugates
The scope of this review is to provide a comprehensive overview of the current synthetic methodologies for both mono- and
Cyclodextrin complexation of selected tyrosine kinase inhibitors
The comprehensive physicochemical characterization and cyclodextrin complexation of four tyrosine kinase inhibitors — erlotinib, gefitinib, vandetanib, and lapatinib — were